fda status bpc-157 compounding pharmacies 2026 advisory committee votes to add popular peptide to drug list FDA Peptide Review 2026: What
FDA Peptide Review 2026: What This Big Shift Means Big news for the peptide space. The FDA Pharmacy Compounding Advisory Committee recently voted eight to six in favor of allowing compounding pharmacies to produce BPC 157. Here is what you need Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for FDA's Review Of Peptides Signals A Growing Public Health Challenge Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest
Pay in 4 interest-free payments of $7.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6


